Gains FDA Approval for Benlysta Autoinjector for Lupus Treatment

finance.yahoo.com/news/gsk-gsk-gains-fda-approval-163920651.html

In This Article:
GSK plc (NYSE:GSK) is one of the 11 best European stocks to invest in. On June 24, the company announced receipt of FDA approval for a 200 mg/mL autoinjector of Benlysta (belimumab) for the treatment of active lupus nephritis (LN). The approval applies to children aged…

This story appeared on finance.yahoo.com, 2025-06-28 16:39:20.
The Entire Business World on a Single Page. Free to Use →